Teprotumumab in advanced reactivated thyroid eye disease

Teprotumumab in advanced reactivated thyroid eye disease

Purpose: To report the case of a patient with reactivated, refractory thyroid eye disease (TED) treated with teprotumumab. Observations: A 51-year-old female with a 16-year history of thyroid eye disease previously treated with orbital decompression and multiple eyelid surgeries presented in a recur...

Full description

Bibliographic Details
Main Authors:	Olivia T. Cheng, Dianne M. Schlachter
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	American Journal of Ophthalmology Case Reports
Subjects:	Thyroid eye disease (TED) Teprotumumab Proptosis Clinical activity score (CAS) Disease recurrence Dysthyroid optic neuropathy (DON)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451993622002304

Similar Items

Early experience with teprotumumab for chronic thyroid eye disease
by: Daniel J. Ozzello, et al.
Published: (2020-09-01)

Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study
by: Connie M. Sears, et al.
Published: (2021-09-01)

Teprotumumab in thyroid eye disease: wonder drug or great divider?
by: Petros Perros, et al.
Published: (2023-06-01)

Severe Hyperglycemia with Teprotumumab for Treatment of Thyroid Eye Disease
by: Savannah Cottom, et al.
Published: (2024-03-01)

Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management
by: Caroline Y Yu, et al.
Published: (2022-01-01)

A Novel Case of Hyperglycemic Hyperosmolar State After the Use of Teprotumumab in a Patient With Thyroid Eye Disease
by: Kajal Shah, MD, et al.
Published: (2022-07-01)

Teprotumumab for the treatment of mild compressive optic neuropathy in thyroid eye disease: A report of two cases
by: Carolina A. Chiou, et al.
Published: (2021-06-01)

The association of race with thyroid eye disease presentation and outcomes
by: Diane Wang, et al.
Published: (2024-01-01)

Effects of teprotumumab on patients with long-standing, active thyroid eye disease
by: Kyle B. Vinson, MD, et al.
Published: (2022-06-01)

Visual morbidity in thyroid eye disease in Asian Indian patients
by: Roshmi Gupta, et al.
Published: (2020-01-01)

Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
by: Brendan K. Bowens, et al.
Published: (2022-11-01)

Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm
by: Wang Y, et al.
Published: (2019-11-01)

Rapid response of thyroid eye disease, peripheral edema, and acropathy to teprotumumab infusion
by: David A. Kelly, et al.
Published: (2024-06-01)

Teprotumumab: a disease modifying treatment for graves’ orbitopathy
by: Michelle Ting, et al.
Published: (2020-07-01)

Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report
by: Tracy J. Lu, et al.
Published: (2023-04-01)

Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series
by: Matthew Chu, et al.
Published: (2022-05-01)

Sight-Threatening Condition in Severe Thyroid Eye Disease: How We Should Manage
by: Yunia Irawati, et al.
Published: (2022-01-01)

Dysthyroid Optic Neuropathy and Barrett’s Index – Revisiting the Cutoffs [Letter]
by: Goel R, et al.
Published: (2022-11-01)

Non-surgical orbital decompression using diuresis in dysthyroid optic neuropathy: a case report
by: Annamaria Erdei, et al.
Published: (2023-01-01)

Orbital radiotherapy plus three-wall orbital decompression in a patient with rare ocular manifestations of thyroid eye disease: case report
by: Shuo Zhang, et al.
Published: (2018-02-01)

Emerging therapies in the medical management of thyroid eye disease
by: Alisha Kamboj, et al.
Published: (2023-12-01)

Orbital lymphocyte populations in three states of thyroid eye disease
by: Shane M. Griffin, et al.
Published: (2023-09-01)

Geometric and Volumetric Measurements of Orbital Structures in CT Scans in Thyroid Eye Disease Classification
by: Yuekun Bao, et al.
Published: (2021-05-01)

Correlation of TED Laterality with Thyroid Status among Thyroid Eye Disease (TED) Patients in a Tertiary Hospital in Indonesia
by: Zahirah Siti Lutfiyah, et al.
Published: (2024-01-01)

A case of pretibial myxedema treated with teprotumumab
by: Lauren Petit, MD, et al.
Published: (2021-10-01)

Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy
by: Kenneth K. H. Lai, et al.
Published: (2023-05-01)

Minimally invasive surgery for thyroid eye disease
by: Milind Neilkant Naik, et al.
Published: (2015-01-01)

Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease
by: Quah Qin Xian N, et al.
Published: (2021-05-01)

Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
by: Lilly H. Wagner, et al.
Published: (2022-11-01)

Adverse reactions and precautions of teprotumumab in the treatment of thyroid-associated ophthalmopathy
by: Yan-Fei Zhu, et al.
Published: (2023-12-01)

A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy
by: Parinee Kemchoknatee, et al.
Published: (2023-01-01)

New drug for thyroid-associated ophthalmopathy——Teprotumumab-trbw
by: Min-Min Jiang, et al.
Published: (2023-04-01)

Sphingolipids in thyroid eye disease
by: Anne Gulbins, et al.
Published: (2023-04-01)

Jod-Basedow phenomenon: Reactivation of thyroid eye disease after contrast computed tomography
by: Roland Hollhumer, et al.
Published: (2018-09-01)

Diagnostic ability of barrett's index to detect dysthyroid optic neuropathy using multidetector computed tomography
by: Mário L. R. Monteiro, et al.
Published: (2008-01-01)

Retrospective Review of Pediatric Thyroid Eye Disease Cases Referred to Nicklaus Children’s Hospital
by: M Enghelberg, et al.
Published: (2018-01-01)

A case of bilateral amyloidosis localized to extraocular muscles mimicking thyroid eye disease
by: Natsuyo Yoshida-Hata, et al.
Published: (2024-01-01)

Retrobulbar hematoma in a patient with thyroid eye disease
by: Christina Y Weng
Published: (2022-01-01)

Dysthyroid optic neuropathy: Demographics, risk factors, investigations, and management outcomes
by: Nisar Sonam Poonam, et al.
Published: (2022-01-01)

Clinical Association of Thyroid Eye Disease with Disease Severity and Thyroid Functional Status-an Experience of a Tertiary Care Hospital, Karachi
by: Bharta Rani, et al.
Published: (2023-05-01)